HealthMap

Microglial M1 Activation and Neuroinflammatory ROS in ALS

Overview

• In the context of Amyotrophic Lateral Sclerosis (ALS), the central nervous system experiences chronic neuroinflammation.
• Microglia, the resident immune cells of the brain and spinal cord, play a critical dual role depending on their polarization state.

The Role of M1 Microglia

• M1 Polarization (Pro-inflammatory State): When microglia are chronically stimulated by pathogens, misfolded proteins (like SOD1, TDP-43), or neuronal debris, they shift into the classic M1 phenotype.
• Cytokine Release: Activated M1 microglia release high levels of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1beta), and interleukin-6.

Generation of Neuroinflammatory ROS

• Oxidative Burst: M1 activation significantly upregulates enzymes such as nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and inducible nitric oxide synthase (iNOS).
• ROS Elevation: This enzymatic upregulation directly drives a massive surge in reactive oxygen species (ROS) and reactive nitrogen species within the microenvironment.
• Excitotoxicity and Damage: The excessive ROS burden leads to oxidative stress, lipid peroxidation, mitochondrial dysfunction, and eventual apoptotic death of adjacent motor neurons, accelerating ALS progression.

Nutritional and Metabolic Considerations (Acu-Cell Perspective)

• Antioxidant Defenses: Managing the neuroinflammatory cascade requires addressing systemic and localized oxidative stress.
• Key Support Factors: Maintaining optimal levels of specific micronutrients—such as vitamin C, vitamin E, coenzyme Q10, and selenium—is critical to help buffer the excessive free radical load generated by hyper-activated M1 microglia.